Meryl George currently serves as the Senior Director of Medical Affairs at Pharmapro-group, where she leverages her extensive experience in global Medical Affairs to drive strategic initiatives that bridge clinical research and commercial operations. With over seven years in the pharmaceutical industry, Meryl has honed...
Meryl George currently serves as the Senior Director of Medical Affairs at Pharmapro-group, where she leverages her extensive experience in global Medical Affairs to drive strategic initiatives that bridge clinical research and commercial operations. With over seven years in the pharmaceutical industry, Meryl has honed her expertise in product lifecycle management, ensuring that each phase—from development to market launch—is meticulously planned and executed. Her role involves not only overseeing the integration of clinical data and regulatory compliance but also enhancing the drug value proposition through innovative medical communications and strategic leadership.
At Pharmapro-group, Meryl has spearheaded key projects that focus on fostering robust relationships with international Key Opinion Leaders (KOLs). By organizing advisory boards and conducting comprehensive literature reviews, she has successfully positioned the company’s products within competitive markets, ensuring that they meet both clinical and commercial needs. Her adeptness in launch strategies has been instrumental in bringing new therapies to market, while her commitment to regulatory compliance ensures that all initiatives align with industry standards.
Meryl’s ability to lead cross-functional teams is a hallmark of her career, enabling her to effectively manage diverse stakeholders and drive consensus on critical medical affairs strategies. As she continues to navigate the complexities of the pharmaceutical landscape, Meryl remains dedicated to enhancing the impact of medical affairs on patient outcomes and advancing the overall mission of Pharmapro-group. Her unique blend of clinical insight and commercial acumen positions her as a pivotal leader in the industry, committed to fostering innovation and excellence in medical affairs.
